Eagle Pharmaceuticals
EGRX
$3.47
Share price
1.31%
Change (1 day)
-83.24%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) - P/B ratio
P/B ratio as of June 2024 : 0.1761
According to Eagle Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 0.1761.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Eagle Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.2695 | -83.46% |
| 2022-12-31 | 1.63 | -56.29% |
| 2021-12-31 | 3.73 | 14.24% |
| 2020-12-31 | 3.26 | -28.62% |
| 2019-12-31 | 4.57 | 31.07% |
| 2018-12-31 | 3.49 | -21.63% |
| 2017-12-31 | 4.45 | -45.2% |
| 2016-12-31 | 8.12 | -47.09% |
| 2015-12-31 | 15.3 | 96.86% |
| 2014-12-31 | 7.80 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 4.99 | 2,735.75% | 🇺🇸 USA |
 Novartis NVS | 5.17 | 2,835.01% | 🇨🇭 Switzerland |
 Eli Lilly LLY | 60.1 | 34,008.41% | 🇺🇸 USA |
 Amgen AMGN | 32.2 | 18,158.79% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 4.93 | 2,700.02% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.51 | 3,028.74% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 2.54 | 1,341.12% | 🇮🇱 Israel |